Fulcrum Therapeutics (FULC) Receives a Buy from Oppenheimer
In a report released today, Matthew Biegler from Oppenheimer maintained a Buy rating on Fulcrum Therapeutics (FULC – Research Report), ...
Gilead, Vertex initiated as new big biotech buys at Citi
Citi has started coverage of Gilead Sciences (NASDAQ:GILD) and Vertex Pharmaceuticals (NASDAQ:VRTX) at buy saying the former will benefit from short-term growth of Biktarvy (bictegravir, emtricitabine ...